SynthesisFrontiers in medicine2026
Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The global aging population has led to a growing number of elderly patients aged ≥75 years undergoing percutaneous coronary intervention (PCI). Frailty is a common geriatric syndrome in this population, related to decreased physiological reserve and reduced ability to cope with stress, and it may significantly affect surgical outcomes. This systematic review aims to comprehensively evaluate the impact of frailty on major clinical outcomes (such as in-hospital mortality, all-cause mortality, bleeding, and stroke) in patients aged ≥75 years after percutaneous coronary intervention. Methods: We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library from inception to December 2025. We included retrospective or prospective cohort studies reporting the relationship between frailty (assessed by any validated tool) and prognosis in elderly patients aged ≥75 years undergoing PCI. Data extraction covered study characteristics, population, age, CAD type, frailty assessment, and outcomes. The Newcastle-Ottawa Scale assessed bias risk. A fixed-effect model was used if Results: This systematic review included a total of 18 cohort studies, comprising 11 retrospective and 7 prospective studies, involving 2,038,546 patients. Our pooled analysis demonstrated that, compared with their non-frail counterparts, frail patients aged ≥75 years had a significantly higher risk of mortality and adverse outcomes following PCI. Specifically, frailty was closely associated with an increased risk of in-hospital death (RR = 3.16, 95% CI: 1.28-7.78) and all-cause death (RR = 2.51, 95% CI: 1.78-3.56). Furthermore, frailty significantly increased the incidence of complications, including the risk of bleeding (RR = 2.26, 95% CI: 1.54-3.31) and stroke (RR = 1.90, 95% CI: 1.86-1.94). The GRADE evidence certainty was low across all outcomes. Conclusion: In patients aged ≥75 years undergoing PCI, frailty is associated with increased risks of in-hospital mortality, all-cause mortality, bleeding, and stroke. These findings support perioperative risk stratification, shared decision-making, and individualized management, though low GRADE evidence and uncertainty warrant caution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.